Healthcare Realty Trust Incorporated
HR · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 932.64M | -317.57M | 78.73M | 40.90M | 0.15 |
| 2023 FY | 1.34B | -618.09M | 49.81M | -278.26M | -0.74 |
| 2024 FY | 1.27B | -555.43M | 36.41M | -654.49M | -1.81 |
| 2025 FY | 1.18B | -396.46M | 94.94M | -246.07M | -0.71 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 13.85B | 6.17B | 60.96M | 5.70B | 7.57B |
| 2023 FY | 12.64B | 5.71B | 25.70M | 5.30B | 6.82B |
| 2024 FY | 10.65B | 5.35B | 68.92M | 4.96B | 5.23B |
| 2025 FY | 9.21B | 4.53B | 26.17M | 4.15B | 4.62B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 272.75M | -163.54M | 109.20M | -1.41B | 47.79M |
| 2023 FY | 499.82M | -231.03M | 268.79M | -472.24M | -35.26M |
| 2024 FY | 501.62M | -248.98M | 252.64M | -457.85M | 43.22M |
| 2025 FY | 457.10M | -330.15M | 126.94M | -386.92M | -42.74M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 4.86B | 10.51B | — | — | — |
| 2023 FY | 6.53B | 11.80B | — | — | — |
| 2024 FY | 6.20B | 11.09B | — | — | — |
| 2025 FY | 5.93B | 10.05B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 297.50M | -107.92M | 16.35M | -157.85M | -0.45 |
| 2025 Q3 | 297.77M | -91.37M | 24.70M | -57.74M | -0.17 |
| 2025 Q4 | 286.30M | -79.25M | 34.38M | 14.39M | 0.04 |
| 2026 Q1 | 278.99M | 178.93M | 32.60M | -56.00K | 0.00 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 10.24B | 5.35B | 25.51M | 4.97B | 4.82B |
| 2025 Q3 | 9.86B | 5.11B | 43.35M | 4.72B | 4.68B |
| 2025 Q4 | 9.21B | 4.53B | 26.17M | 4.15B | 4.62B |
| 2026 Q1 | 9.15B | 4.65B | 26.24M | 4.34B | 4.44B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 163.22M | -85.65M | 77.56M | -108.95M | -215.00K |
| 2025 Q3 | 113.75M | -88.82M | 24.93M | -84.77M | 17.84M |
| 2025 Q4 | 132.34M | -86.55M | 45.79M | -84.39M | -17.33M |
| 2026 Q1 | 52.88M | -61.15M | -8.28M | -83.90M | 63.00K |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 5.55B | 10.49B | — | — | — |
| 2025 Q3 | 6.31B | 10.99B | — | — | — |
| 2025 Q4 | 5.93B | 10.05B | — | — | — |
| 2026 Q1 | 5.90B | 10.22B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |